Does menopause reduce ovarian steroid production and affect energy, body composition, and weight regulation?

Menopause triggers a profound metabolic and endocrine transition, initiated by ovarian senescence and follicular depletion. This shift significantly alters hormone profiles, directly impacting cellular bioenergetics and physical structure.

Hormonal shift and steroidogenesis

• Estradiol collapse: Severe depletion of ovarian follicles causes a sharp, persistent drop in systemic estradiol, which frequently stabilizes below 10–20 pg/mL.
• Gradual testosterone decline: Ovarian androgen synthesis decreases more gradually than estradiol. The remaining ovarian stroma, stimulated by elevated luteinizing hormone, along with peripheral conversion of adrenal precursors, helps preserve a degree of circulating testosterone.

Cellular mechanisms of energy and fatigue

• Mitochondrial dysfunction: Depletion of estradiol downregulates PGC-1α and related transcription factors, leading to impaired mitochondrial biogenesis and elevated oxidative stress in skeletal muscle.
• Decreased ATP production: Both estradiol and testosterone support mitochondrial respiratory chain integrity and ATP synthesis. Their decline triggers bioenergetic failure in skeletal muscle, driving clinical fatigability.

Body composition and metabolic regulation

• Visceral fat accumulation: Lower estradiol levels reduce resting and total energy expenditure, decrease lipid oxidation, and shift adipose deposition toward visceral and abdominal compartments.
• Sarcopenia and lean mass loss: Reduced testosterone availability impairs mitochondrial protection in skeletal muscle, accelerating cell death pathways and muscle atrophy. Conversely, physiological testosterone replacement in postmenopausal women has been shown to increase lean body mass and reduce overall fat mass.

Bottom line

• Menopause-induced declines in estradiol and testosterone systematically impair skeletal muscle mitochondrial function and energy expenditure. This bioenergetic shift directly drives postmenopausal fatigue, muscle loss, and visceral fat accumulation.